Developing a machine learning model to assist in predicting treatment success in children with drug-resistant
Achmad Rafli1,2, Wisnu Ananta Kusuma3,4, Setyo Handryastuti2
1Doctoral Program in Medical Sciences, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Insights
Machine learning models can predict treatment success for children with drug-resistant epilepsy. Integrating clinical data, EEG, and MRI helps personalize antiepileptic drug selection for better seizure control.
Area of Science:
- Neurology
- Artificial Intelligence
- Pediatric Medicine
Background:
- Drug-resistant epilepsy (DRE) in children presents significant treatment challenges due to patient variability.
- Current antiepileptic drug (AED) selection often struggles to achieve consistent seizure reduction in pediatric DRE.
- Personalized treatment strategies are crucial for improving outcomes in pediatric epilepsy.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting treatment success in pediatric patients with DRE.
- To identify the optimal machine learning algorithm for forecasting treatment outcomes.
- To create a decision support tool for clinicians managing pediatric DRE.
Main Methods:
- An ambispective cohort of 215 pediatric patients with DRE was studied.
- Data included clinical information, electroencephalography (EEG), and Magnetic Resonance Imaging (MRI).
- Machine learning algorithms (SVM, DT, RF, GB) were employed and compared for predictive performance.
Main Results:
- Machine learning models integrated diverse data types to predict treatment success.
- Comparative analysis identified the most effective algorithm for forecasting seizure control.
- The study establishes a novel approach for predicting therapeutic response in pediatric DRE.
Conclusions:
- Machine learning offers a promising approach to personalize AED selection for pediatric DRE.
- The developed model can aid neurologists in predicting seizure control and guiding therapeutic adjustments.
- This research pioneers the use of integrated data with machine learning for DRE management in Indonesia.
Abstract:
Currently, the successfulness of reducing seizures through the selection of appropriate antiepileptic drugs (AED) in children with drug-resistant epilepsy remains a challenge due to variability characteristic in patients. This study aims to develop and evaluate machine learning models to treatment success in pediatric patients with drug-resistant epilepsy. This study will be conducted with an ambispective cohort. A total of 215 subjects will be taken from patients in Cipto Mangunkusumo Referral Hospital and Harapan Kita Child and Mother Hospital Jakarta, Indonesia. Supporting examinations will be also performed such as electroencephalography (EEG) and modified HARNESS Magnetic Resonance Imaging (MRI). The collected data will be analyzed by machine learning with several algorithms including support vector machine (SVM), decision tree (DT), random forest (RF), gradient boosting (GB), and their performance will be compared to determine the best model. This is the first study to utilize machine learning by integrating clinical data, EEG, MRI, and medication history to predict treatment success in pediatric patients with drug-resistant epilepsy in Indonesia. The developed model is expected to serve as a clinical decision supporting tool for pediatric neurologists to predict seizure control in children with DRE and determine appropriate therapeutic adjustments with more aggressively when uncontrolled seizures are predicted.
More Related Videos
09:49Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
09:29Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
